We are searching data for your request:
Forums and discussions:
Manuals and reference books:
Data from registers:
Upon completion, a link will appear to access the found materials.
First, you will apply the CRISPR genetic status in the human body to try to cure congenital and hereditary blindness.First they try to bleach blindness through gene editingFirst, we will apply the CRISPR programmed gene editing system in the human body to try to cure a terrible eye disease, Leber's blindfold, patients are currently being selected for the first such scientific research. The rare disease appears as early as childbirth or the first few months of life. The patient lacks a gene that prevents the healthy development of photoreceptor cells. Experimental drug treatment aims to genotype a child or adult who lacks this gene by using a healthy version of this gene, but will not will be hereditary.
Two American pharmaceutical companies, Editas Medicine and Allergan, are testing 18 people in Transit Technology in the United States, among others at the Harvard University College of Education, Eye and Ear in Boston, Massachusetts.This kind of gene editing in the human body differs from that done by the Chinese researcher Ho Chian-ku last yearwhen he changed his twin gene strain with the "molecular grade" to prevent the babies from catching the HIV virus that their father was infected with. Children can pass on their altered genes to their offspring. Leber's congenital blindness has already been successfully treated with gene therapy in some patients. In these cases, the altered virus was used to deliver healthy genes by injection into cells in the retina.
- Newly engineered dolls may come
- Hereditary diseases can be re-edited
- Here are the first twin twins